107 related articles for article (PubMed ID: 22350135)
1. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus.
Kristensen D; Prats C; Larsen S; Ara I; Dela F; Helge JW
Acta Diabetol; 2013 Oct; 50(5):705-12. PubMed ID: 22350135
[TBL] [Abstract][Full Text] [Related]
2. Human muscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes.
Albers PH; Pedersen AJ; Birk JB; Kristensen DE; Vind BF; Baba O; Nøhr J; Højlund K; Wojtaszewski JF
Diabetes; 2015 Feb; 64(2):485-97. PubMed ID: 25187364
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity.
He J; Watkins S; Kelley DE
Diabetes; 2001 Apr; 50(4):817-23. PubMed ID: 11289047
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
5. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?
Gaster M; Staehr P; Beck-Nielsen H; Schrøder HD; Handberg A
Diabetes; 2001 Jun; 50(6):1324-9. PubMed ID: 11375332
[TBL] [Abstract][Full Text] [Related]
6. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.
Serlie MJ; Meijer AJ; Groener JE; Duran M; Endert E; Fliers E; Aerts JM; Sauerwein HP
J Clin Endocrinol Metab; 2007 Apr; 92(4):1524-9. PubMed ID: 17264178
[TBL] [Abstract][Full Text] [Related]
7. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
8. GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?
Gaster M; Ottosen PD; Vach W; Christiansen H; Staehr P; Beck-Nielsen H; Schrøder HD
APMIS; 2003 Feb; 111(2):338-48. PubMed ID: 12716391
[TBL] [Abstract][Full Text] [Related]
9. Muscle glycogen content in type 2 diabetes mellitus.
He J; Kelley DE
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E1002-7. PubMed ID: 15251866
[TBL] [Abstract][Full Text] [Related]
10. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.
Lopez X; Goldfine AB; Holland WL; Gordillo R; Scherer PE
J Pediatr Endocrinol Metab; 2013; 26(9-10):995-8. PubMed ID: 23612696
[TBL] [Abstract][Full Text] [Related]
11. Endurance training modulates intramyocellular lipid compartmentalization and morphology in skeletal muscle of lean and obese women.
Devries MC; Samjoo IA; Hamadeh MJ; McCready C; Raha S; Watt MJ; Steinberg GR; Tarnopolsky MA
J Clin Endocrinol Metab; 2013 Dec; 98(12):4852-62. PubMed ID: 24081737
[TBL] [Abstract][Full Text] [Related]
12. Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.
Skovbro M; Baranowski M; Skov-Jensen C; Flint A; Dela F; Gorski J; Helge JW
Diabetologia; 2008 Jul; 51(7):1253-60. PubMed ID: 18458871
[TBL] [Abstract][Full Text] [Related]
13. Effect of weight loss on muscle lipid content in morbidly obese subjects.
Gray RE; Tanner CJ; Pories WJ; MacDonald KG; Houmard JA
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E726-32. PubMed ID: 12488242
[TBL] [Abstract][Full Text] [Related]
14. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.
Straczkowski M; Kowalska I; Baranowski M; Nikolajuk A; Otziomek E; Zabielski P; Adamska A; Blachnio A; Gorski J; Gorska M
Diabetologia; 2007 Nov; 50(11):2366-73. PubMed ID: 17724577
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: a potential factor in ceramide accumulation.
Thrush AB; Brindley DN; Chabowski A; Heigenhauser GJ; Dyck DJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):5053-61. PubMed ID: 19837942
[TBL] [Abstract][Full Text] [Related]
16. Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness.
Stuart CA; McCurry MP; Marino A; South MA; Howell ME; Layne AS; Ramsey MW; Stone MH
J Clin Endocrinol Metab; 2013 May; 98(5):2027-36. PubMed ID: 23515448
[TBL] [Abstract][Full Text] [Related]
17. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
18. Endurance training alters skeletal muscle MCT contents in T2DM men.
Opitz D; Lenzen E; Schiffer T; Hermann R; Hellmich M; Bloch W; Brixius K; Brinkmann C
Int J Sports Med; 2014 Dec; 35(13):1065-71. PubMed ID: 25009968
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.
Broskey NT; Obanda DN; Burton JH; Cefalu WT; Ravussin E
Metabolism; 2018 May; 82():118-123. PubMed ID: 29307520
[TBL] [Abstract][Full Text] [Related]
20. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.
Blachnio-Zabielska A; Baranowski M; Zabielski P; Gorski J
J Cell Physiol; 2010 Nov; 225(3):786-91. PubMed ID: 20568228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
